US Stock MarketDetailed Quotes

QNRX Quoin Pharmaceuticals

Watchlist

0.6202
+0.0132+2.17%

Close Nov 15 16:00 ET

0.6391
+0.0189+3.05%

Post 16:50 ET

3.13MMarket Cap-169P/E (TTM)

Quoin Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

18.95%2.53M

-5.44%2.14M

-11.43%2.46M

1.30%9.38M

6.32%2.22M

-8.69%2.13M

-15.30%2.26M

27.55%2.78M

52.70%9.26M

-30.04%2.09M

Selling and administrative expenses

-0.64%1.36M

-1.05%1.62M

-4.06%1.62M

-7.81%6.07M

-5.95%1.39M

-13.63%1.37M

-15.79%1.63M

6.00%1.68M

46.33%6.58M

-25.41%1.47M

-General and administrative expense

-0.64%1.36M

-1.05%1.62M

-4.06%1.62M

-7.81%6.07M

-5.95%1.39M

-13.63%1.37M

-15.79%1.63M

6.00%1.68M

46.33%6.58M

-25.41%1.47M

Research and development costs

54.24%1.17M

-16.92%519.35K

-22.80%842.83K

23.76%3.31M

35.77%832.39K

1.78%758.76K

-13.98%625.1K

85.81%1.09M

71.01%2.67M

-39.11%613.07K

Operating profit

-18.95%-2.53M

5.44%-2.14M

11.43%-2.46M

-1.30%-9.38M

-6.32%-2.22M

8.69%-2.13M

15.30%-2.26M

-27.55%-2.78M

-52.70%-9.26M

30.04%-2.09M

Net non-operating interest income expense

-25.47%146.39K

-11.90%165.26K

-9.56%137.51K

212.34%694.61K

96.68%158.55K

128.10%196.43K

187.59K

152.05K

54.71%-618.34K

114.04%80.61K

Non-operating interest income

-25.47%146.39K

-11.90%165.26K

-9.56%137.51K

625.48%694.61K

96.68%158.55K

1,198.08%196.43K

--187.59K

--152.05K

--95.75K

--80.61K

Non-operating interest expense

----

--0

----

-34.51%714.08K

--0

Other net income (expense)

1,397.36%31.73K

93.68%-2.18K

-131.86%-6.51K

-100.54%-2.68K

112.00%9.24K

169.41%2.12K

-34.47K

-95.86%20.43K

103.52%494.54K

100.05%4.36K

Gain on sale of security

1,397.36%31.73K

93.68%-2.18K

-131.86%-6.51K

-305.28%-2.68K

112.68%9.24K

169.41%2.12K

---34.47K

-73.55%20.43K

--1.31K

---72.88K

Special income (charges)

----

--0

----

--416K

--0

-Less:Other special charges

----

---416K

--0

Other non- operating income (expenses)

----

100.55%77.24K

----

Income before tax

-21.97%-2.35M

6.31%-1.97M

10.59%-2.33M

7.41%-8.69M

-2.44%-2.05M

36.40%-1.93M

21.03%-2.11M

-54.69%-2.6M

56.29%-9.38M

83.07%-2M

Income tax

Net income

-21.97%-2.35M

6.31%-1.97M

10.59%-2.33M

7.41%-8.69M

-2.44%-2.05M

36.40%-1.93M

21.03%-2.11M

-54.69%-2.6M

56.29%-9.38M

83.07%-2M

Net income continuous Operations

-21.97%-2.35M

6.31%-1.97M

10.59%-2.33M

7.41%-8.69M

-2.44%-2.05M

36.40%-1.93M

21.03%-2.11M

-54.69%-2.6M

56.29%-9.38M

83.07%-2M

Minority interest income

Net income attributable to the parent company

-21.97%-2.35M

6.31%-1.97M

10.59%-2.33M

7.41%-8.69M

-2.44%-2.05M

36.40%-1.93M

21.03%-2.11M

-54.69%-2.6M

56.29%-9.38M

83.07%-2M

Preferred stock dividends

Other preferred stock dividends

65.27K

Net income attributable to common stockholders

-21.97%-2.35M

6.31%-1.97M

10.59%-2.33M

8.05%-8.69M

-2.44%-2.05M

37.75%-1.93M

21.03%-2.11M

-54.69%-2.6M

55.98%-9.45M

83.07%-2M

Basic earnings per share

75.90%-0.47

81.69%-0.39

72.86%-1.11

79.41%-9.64

58.09%-2.0764

82.71%-1.95

94.53%-2.13

86.42%-4.09

94.26%-46.81

97.66%-4.9543

Diluted earnings per share

75.90%-0.47

81.69%-0.39

72.86%-1.11

79.41%-9.64

58.02%-2.08

82.71%-1.95

94.53%-2.13

86.42%-4.09

94.26%-46.81

97.66%-4.9543

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	18.95%2.53M	-5.44%2.14M	-11.43%2.46M	1.30%9.38M	6.32%2.22M	-8.69%2.13M	-15.30%2.26M	27.55%2.78M	52.70%9.26M	-30.04%2.09M
Selling and administrative expenses	-0.64%1.36M	-1.05%1.62M	-4.06%1.62M	-7.81%6.07M	-5.95%1.39M	-13.63%1.37M	-15.79%1.63M	6.00%1.68M	46.33%6.58M	-25.41%1.47M
-General and administrative expense	-0.64%1.36M	-1.05%1.62M	-4.06%1.62M	-7.81%6.07M	-5.95%1.39M	-13.63%1.37M	-15.79%1.63M	6.00%1.68M	46.33%6.58M	-25.41%1.47M
Research and development costs	54.24%1.17M	-16.92%519.35K	-22.80%842.83K	23.76%3.31M	35.77%832.39K	1.78%758.76K	-13.98%625.1K	85.81%1.09M	71.01%2.67M	-39.11%613.07K
Operating profit	-18.95%-2.53M	5.44%-2.14M	11.43%-2.46M	-1.30%-9.38M	-6.32%-2.22M	8.69%-2.13M	15.30%-2.26M	-27.55%-2.78M	-52.70%-9.26M	30.04%-2.09M
Net non-operating interest income expense	-25.47%146.39K	-11.90%165.26K	-9.56%137.51K	212.34%694.61K	96.68%158.55K	128.10%196.43K	187.59K	152.05K	54.71%-618.34K	114.04%80.61K
Non-operating interest income	-25.47%146.39K	-11.90%165.26K	-9.56%137.51K	625.48%694.61K	96.68%158.55K	1,198.08%196.43K	--187.59K	--152.05K	--95.75K	--80.61K
Non-operating interest expense	----	----	----	--0	----	----	----	----	-34.51%714.08K	--0
Other net income (expense)	1,397.36%31.73K	93.68%-2.18K	-131.86%-6.51K	-100.54%-2.68K	112.00%9.24K	169.41%2.12K	-34.47K	-95.86%20.43K	103.52%494.54K	100.05%4.36K
Gain on sale of security	1,397.36%31.73K	93.68%-2.18K	-131.86%-6.51K	-305.28%-2.68K	112.68%9.24K	169.41%2.12K	---34.47K	-73.55%20.43K	--1.31K	---72.88K
Special income (charges)	----	----	----	--0	----	----	----	----	--416K	--0
-Less:Other special charges	----	----	----	----	----	----	----	----	---416K	--0
Other non- operating income (expenses)	----	----	----	----	----	----	----	----	100.55%77.24K	----
Income before tax	-21.97%-2.35M	6.31%-1.97M	10.59%-2.33M	7.41%-8.69M	-2.44%-2.05M	36.40%-1.93M	21.03%-2.11M	-54.69%-2.6M	56.29%-9.38M	83.07%-2M
Income tax
Net income	-21.97%-2.35M	6.31%-1.97M	10.59%-2.33M	7.41%-8.69M	-2.44%-2.05M	36.40%-1.93M	21.03%-2.11M	-54.69%-2.6M	56.29%-9.38M	83.07%-2M
Net income continuous Operations	-21.97%-2.35M	6.31%-1.97M	10.59%-2.33M	7.41%-8.69M	-2.44%-2.05M	36.40%-1.93M	21.03%-2.11M	-54.69%-2.6M	56.29%-9.38M	83.07%-2M
Minority interest income
Net income attributable to the parent company	-21.97%-2.35M	6.31%-1.97M	10.59%-2.33M	7.41%-8.69M	-2.44%-2.05M	36.40%-1.93M	21.03%-2.11M	-54.69%-2.6M	56.29%-9.38M	83.07%-2M
Preferred stock dividends
Other preferred stock dividends				0					65.27K	0
Net income attributable to common stockholders	-21.97%-2.35M	6.31%-1.97M	10.59%-2.33M	8.05%-8.69M	-2.44%-2.05M	37.75%-1.93M	21.03%-2.11M	-54.69%-2.6M	55.98%-9.45M	83.07%-2M
Basic earnings per share	75.90%-0.47	81.69%-0.39	72.86%-1.11	79.41%-9.64	58.09%-2.0764	82.71%-1.95	94.53%-2.13	86.42%-4.09	94.26%-46.81	97.66%-4.9543
Diluted earnings per share	75.90%-0.47	81.69%-0.39	72.86%-1.11	79.41%-9.64	58.02%-2.08	82.71%-1.95	94.53%-2.13	86.42%-4.09	94.26%-46.81	97.66%-4.9543
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data